Influenza News and Research

Latest Influenza News and Research

Maxim Health Systems cancels all flu shot clinics at retail locations

Maxim Health Systems has cancelled all flu shot clinics at retail locations after October 22, due to lack of vaccine availability. Across the country, there has been a drastic increase in both demand and media attention regarding influenza and vaccine availability. While the nation is experiencing an increase in demand for flu vaccine, manufacturers are unable to produce more seasonal flu vaccine because all resources have been shifted to H1N1 production.

24 Oct 2009

African American seniors less likely to be vaccinated against flu; fear and misinformation pose problems

A study about why African American seniors do or do not get influenza vaccinations finds that many of them do not have accurate and complete information about the flu itself, the safety and efficacy of the inoculations, and the ease and necessity of getting the shots.

24 Oct 2009

Pregnant women unsure about getting H1N1 flu shot, shows new survey

Despite majorities expressing concern about getting the novel H1N1 (or swine) flu this year, only about one in four pregnant women or new mothers plan to get the H1N1 flu shot, according to findings from a new survey conducted on behalf of HealthyWomen by Harris Interactive.

24 Oct 2009

Pennsylvania allocated 566,000 doses of H1N1 vaccine

The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.

24 Oct 2009

Ontario doctors urge employers not to ask sick note from a physician for employees taking leave this flu season

In advance of what is shaping up to be an unprecedented flu season, Ontario's doctors are encouraging employers to reconsider asking their employees for a sick note from a physician because of an absence from work.

24 Oct 2009

FDA issues emergency use authorization for intravenous antiviral drug peramivir in H1N1 patients

The U.S. Food and Drug Administration announced today that, in response to a request from the U.S. Centers for Disease Control and Prevention, it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.

24 Oct 2009

Preachers Coffee signs agreement to enhance its nutraceutical-health marketing strategy

PREACHERS COFFEE, INC. (PINKSHEETS: PRCF) in order to enhance its Nutraceutical Health Marketing Strategy entered into an Agreement with "GANO EXCEL COFFEE COMPANY" -- a robust Multi Level Marketing Health Coffee Company that has a broad range of 3,000,000 customers with respect to population and followings.

23 Oct 2009

ISHLT Infectious Disease Council issues new H1N1 advisory for cardiothoracic transplantation programs

Each year 3-5 million people have severe cases and 250-500,000 die from complications of seasonal influenza world-wide. This year, the novel 2009 H1N1 (nH1N1) influenza, previously called swine flu, has reached pandemic status.

23 Oct 2009

Practical guidance for cardiothoracic transplant programs in view of H1N1 flu pandemic

23 Oct 2009

Sinovac Biotech to distribute PANFLU.1 vaccine in Mexico

Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, today announced that it has received a Certificate of Approval from the Secretaria de Salud to distribute PANFLU.1, its H1N1 pandemic influenza (swine flu) vaccine, in Mexico. The certificate is valid through October 13, 2014.

23 Oct 2009

Notificateur communications tool: Preventive measure for influenza A virus

In preparation for the second wave of the influenza A (H1N1) virus, Hi-VOS proposes a fast and effective communications tool to help public institutions and businesses better communicate with various groups among the Canadian population: employees, parents, students and clients.

23 Oct 2009

MedImmune announces interim data from its live attenuated influenza vaccine studies

MedImmune announced today that interim data from human studies of its nasal spray vaccine for the 2009 novel Influenza A (H1N1) virus demonstrate a similar clinical profile in children and adults 2 to 49 years of age as previously studied seasonal formulations of the vaccine.

23 Oct 2009

Gen-Probe acquires Prodesse

Gen-Probe announced today that the Company has completed its acquisition of Prodesse, Inc., a leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash.

23 Oct 2009

Some hospital revenues could decline if H1N1 becomes pandemic

"While it's common for hospitals to see a revenue boost at the onset of seasonal influenza season, the additional threat of cases from the H1N1 swine flu virus could complicate this fall's and winter's financial picture for such health facilities," The Chicago Tribune reports.

23 Oct 2009

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.

23 Oct 2009

Majority of allergy patients can be vaccinated against swine flu after evaluation by an allergist

Once supply catches up with the immediate demand for H1N1 "swine" flu vaccine, some allergy patients who could benefit from the vaccine may needlessly avoid it due to confusion over who should, and should not, be vaccinated, cautions Dr. Peter R. Smith, a board-certified allergist and clinical immunologist with Allergy Partners of Fredericksburg, Virginia.

23 Oct 2009

45% of American adults not inclined to get vaccinated against seasonal flu

Two in five at-risk American adults who would benefit from vaccination against seasonal flu are missing out on the protective shots because they believe they do not need them and are not inclined to be vaccinated. And among those who say they do intend to take up the vaccine, nearly half get around to it, according to Dr. Katharine Harris from the RAND Corporation in Arlington, USA, and her team.

23 Oct 2009

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.

22 Oct 2009

Schering-Plough announces 2009 third quarter financial results

Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2009 third quarter.

22 Oct 2009

More infants are being immunized but funding gap leaves millions of children still at risk

Reversing a downward trend, immunization rates are now at their highest ever and vaccine development worldwide is booming, according to a new assessment released today by the World Health Organization (WHO), UNICEF and the World Bank.

22 Oct 2009

Influenza News and Research

Latest Influenza News and Research

Maxim Health Systems cancels all flu shot clinics at retail locations

African American seniors less likely to be vaccinated against flu; fear and misinformation pose problems

Pregnant women unsure about getting H1N1 flu shot, shows new survey

Pennsylvania allocated 566,000 doses of H1N1 vaccine

Ontario doctors urge employers not to ask sick note from a physician for employees taking leave this flu season

FDA issues emergency use authorization for intravenous antiviral drug peramivir in H1N1 patients

Preachers Coffee signs agreement to enhance its nutraceutical-health marketing strategy

ISHLT Infectious Disease Council issues new H1N1 advisory for cardiothoracic transplantation programs

Practical guidance for cardiothoracic transplant programs in view of H1N1 flu pandemic

Sinovac Biotech to distribute PANFLU.1 vaccine in Mexico

Notificateur communications tool: Preventive measure for influenza A virus

MedImmune announces interim data from its live attenuated influenza vaccine studies

Gen-Probe acquires Prodesse

Some hospital revenues could decline if H1N1 becomes pandemic

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

Majority of allergy patients can be vaccinated against swine flu after evaluation by an allergist

45% of American adults not inclined to get vaccinated against seasonal flu

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Schering-Plough announces 2009 third quarter financial results

More infants are being immunized but funding gap leaves millions of children still at risk

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Influenza News and Research

Latest Influenza News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in